Article

Epithelial mesenchymal transition and resistance to neoadjuvant radiotherapy in locally advanced rectal cancer

2014-01-01

Abstract excerpt

Background: Non-response to neoadjuvant therapy is a significant challenge for clinicians managing solid cancers. This thesis aimed to determine whether Epithelial Mesenchymal Transition (EMT) was associated with non-response to neoadjuvant therapy in patients with locally advanced rectal cancer. Methods: Representative tissue specimens from the tumour invasive front of consecutive patients undergoing resection of...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: a9d202de-2982-5af8-b540-b48f7aabfdc3
DOI: 10.25560/24734

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Epithelial mesenchymal transition and resistance to neoadjuvant radiotherapy in locally advanced rectal cancerDOI 10.25560/24734Read

Tumor microRNAs Identified by Small RNA Sequencing as Potential Response Predictors in Locally Advanced Rectal Cancer Patients Treated With Neoadjuvant ChemoradiotherapySemantic proximity Read

Gene and MicroRNA Expression Are Predictive of Tumor Response in Rectal Adenocarcinoma Patients Treated With Preoperative ChemoradiotherapySemantic proximity Read

Molecular differentiation between complete and incomplete responders to neoadjuvant therapy in rectal cancerSemantic proximity Read

New specific molecular targets for radio‐chemotherapy of rectal cancerSemantic proximity Read

MiR-200a regulates epithelial to mesenchymal transition-related gene expression and determines prognosis in colorectal cancer patientsSemantic proximity Read

Expression Profiling of Rectal Tumors Defines Response to Neoadjuvant Treatment Related GenesSemantic proximity Read

KRAS Mutant Status May Be Associated with Distant Recurrence in Early-stage Rectal Cancer.Semantic proximity Read

Response to neoadjuvant chemoradiotherapy in rectal cancer is associated with RAS/AKT pathway dysregulation and high tumour mutational burdenSemantic proximity Read

Identification of neoadjuvant radiotherapy resistance genes in rectal cancer using integrated bioinformatics analysisSemantic proximity Read

Pathological Response Has Survival Benefits for Rectal Cancer following Neoadjuvant TherapySemantic proximity Read

KRAS Mutant Status, p16 and β-catenin Expression May Predict Local Recurrence in Patients Who Underwent Transanal Endoscopic Microsurgery (TEMS) for Stage I Rectal Cancer.Semantic proximity Read

OCT4 Potentiates Radio-Resistance and Migration Activity of Rectal Cancer Cells by Improving Epithelial-Mesenchymal Transition in a ZEB1 Dependent MannerSemantic proximity Read